INTRODUCTION
Neuritic plaques containing deposits of Ab are hallmark pathologies of Alzheimer's disease. Ab is a 40-42 amino acid peptide that is derived by proteolytic cleavage from a precursor, the amyloid precursor protein (APP). APP is a type-1 membrane-spanning protein and the Ab sequence resides partly within the extracellular and membrane-spanning domains [see for review (1) ].
A number of lines of evidence support the notion that altered APP processing leading to increased production, aggregation and deposition of Ab are major pathogenic events in Alzheimer's disease [see for review (2) ]. Indeed, elevated levels of Ab have been linked to memory defects and changes in synaptic plasticity in a variety of animal models of Alzheimer's disease [see for reviews (3, 4) ]. One such model is the APPsweTg2576 (APPswe) transgenic mouse which expresses a familial Alzheimer's disease mutant APP gene that contains the 'Swedish' double mutation Lys 670 Asn/Met 671 Leu (5) . APPswe mice are one of the most widely studied models of Alzheimer's disease and develop Ab amyloid pathology and also age-related defects in spatial reference memory and longterm potentiation (LTP) that correlate with increasing levels of cerebral Ab (6) (7) (8) (9) . Such studies have highlighted reduction of cerebral Ab load as a prime target for therapeutic intervention in Alzheimer's disease.
X11b (also known as X11-like/munc-18-interacting protein-2; mint2) is a neuronal adaptor protein that binds to the intracellular domain of APP (10 -13) . This interaction is mediated by a central phospho-tyrosine-binding (PTB) domain in X11b and sequences surrounding the YENPTY motif in APP [see for reviews (14, 15) ]. Alterations to X11b expression influence APP processing and Ab production. In particular, elevation of X11b inhibits Ab production in cellular models and inhibits Ab production and deposition in the brains of APPswe transgenic mice (12,16 -20) . Such observations suggest that modulation of X11b function might prove therapeutic in Alzheimer's disease. Here, we show that X11b not only inhibits cerebral Ab production, but additionally corrects age-dependent defects in both cognition and in vivo LTP in aged Alzheimer's disease APPswe Tg2576 mice.
RESULTS

Overexpression of X11b has no detrimental effect on sensorimotor function in APPswe Tg2576 mice
To investigate the effect of X11b on cerebral Ab levels, memory function and LTP, we crossed X11b overexpressing transgenic mice (16) with APPswe Tg2576 (APPswe) transgenic mice (5) . APPswe mice show age-related defects in spatial reference memory and LTP that correlate with increasing levels of cerebral Ab (6 -9) . Analyses of the offspring from the cross revealed that their genotypes approximated to that expected of Mendelian inheritance; 1/4 each nontransgenic (NTg); APPswe; X11b; APPswe/X11b. Mice were analyzed at 3 -5 months and at 12-16 months of age. Up to 6 months of age, APPswe mice have normal memory function and no Ab pathology but then develop memory and LTP defects that correlate with increasing Ab load (6, 8, 21 ). There were no significant age differences between the four genotypes in the 3 -5 months age group; likewise there were no significant differences between the four genotypes in the 12-16 months age group. Finally, no significant differences in sex ratios between genotypes were detected in either age group (chi-square analyses). Male and female mice were thus pooled for analyses.
Both the 3 -5 and 12-16 months mice were analyzed for sensorimotor defects using the SHIRPA primary screen (22) . No differences between the four genotypes were detected at either age demonstrating that overexpression of X11b has no overt detrimental effect on sensorimotor function in either the absence or presence of the APPswe transgene. However, on open-field testing 12-16 months but not 3 -5 months APPswe and APPswe/X11b mice both displayed significant 1.5-2-fold increases in distance travelled and rearing frequencies compared with both NTg and X11b animals ( Fig. 1) . In contrast, no differences between genotype in either the 3 -5 or 12-16-month-old mice in the total time spent within, and number of entries into the central zone of the open-field arena were detected (one-way Anova, 3 -5-month-old mice, n ¼ 12-20; 12-16 months mice, n ¼ 17-21). Previous studies of motor activity in APPswe mice have produced inconsistent results with reports of hyperactivity in three but not 9-month-old animals, hyperactivity in 17-month-old mice and no differences between APPswe and their NTg littermates at 16-18 months (6, 23, 24) . Recently, an increase in locomotor activity has been linked to behavioural disinhibition in APPswe mice (25) . Whatever, our finding that X11b overexpression does not influence locomotor activity in either the presence or absence of APPswe, suggests that the presence of the X11b transgene is unlikely to confound interpretation of assays of memory function in the Morris water maze which rely in part on locomotor function. Moreover, since X11b overexpression reduces cerebral Ab levels (16) (and see below) the effect of APPswe on locomotor activity in 12-16 months mice may not be linked to cerebral Ab load. Rather, the effect may be a functional consequence of APP (or APPswe) overexpression per se.
X11b reduces cerebral Ab levels in APPswe Tg2576 mice
We analyzed brain Ab 1 -40 and Ab 1 -42 levels in APPswe and APPswe/X11b littermates. In young APPswe mice (up to 6 months), Ab species are mainly soluble in aqueous buffers (Tris -HCl-soluble Ab) but in older mice, Ab levels increase dramatically and require solubilisation in agents such as formic acid (formic acid-soluble Ab) (7, 16) . We therefore prepared Tris -HCl-soluble and formic acid-soluble fractions for analyses. In 3 -5 months animals, X11b significantly reduced Tris -HCl-soluble Ab 1 -40 but not Ab 1 -42 levels. The lack of an effect of X11b on Ab 1 -42 levels may be partly a consequence of the relatively low levels of this species in the brains of APPswe mice at this young age and the consequent difficulties in its robust detection. Indeed, this lack of effect of X11b on Ab 1 -42 levels in young APPswe mice is consistent with previous reports in these mice (16) . Formic acid-soluble Ab 1 -40 and Ab 1 -42 levels in 3 -5-month-old mice were below the level of accurate detection by the commercial ELISA kits used here ( Fig. 2A) . Again this is in agreement with previous studies that also reported very low levels of formic acid-soluble Ab 1 -40 and Ab 1 -42 in mice up to 6 months of age and which were difficult to robustly detect (7, 16) . However, in 12-16-month-old APPswe mice, formic acid-soluble Ab levels increase by over a thousand-fold (7, 16) . At this age, X11b induced significant decreases in both Tris -HCl-soluble and formic acid-soluble Ab 1 -40 and Ab 1 -42 levels (Fig. 2B) . Of particular interest, X11b reduced total Ab 1 -40 and Ab 1 -42 levels by approximately 50 and 40%, respectively, in the 12-16 months mice. We have previously shown that X11b also markedly reduces Ab plaque numbers in APPswe transgenic mice (16) .
X11b rescues spatial reference memory deficits in aged APPswe mice
To determine the effect of X11b on age-related memory loss in APPswe mice, we tested spatial reference memory function in NTg, APPswe, X11b and APPswe/X11b mice using the Morris water maze at both 3 -5 and 12 -16 months of age. For these studies, we performed visible platform training followed by hidden platform testing with three rounds of probe trials as described by others for APPswe Tg2576 mice (8, 21) . All genotypes in both age groups were able to learn the location of the visible platform by 3 days of training ( Fig. 3A and B) and within each age group were similarly proficient swimmers (data not shown). However, APPswe and APPswe/X11b 12 -16 months but not 3 -5-month-old mice both had increased escape latencies (time in seconds to reach the platform) compared with NTg and X11b littermate mice in the first three training blocks ( Fig. 3A and B) . This is consistent with previous studies that likewise demonstrated an initial lag in performance to reach the visible platform in middle aged (12 -18 months) but not young (4 -5 months) APPswe Tg2576 mice (8) . Despite this lag in older APPswe and APPswe/X11b mice, the finding that there were no significant differences between any genotype in the last three training blocks mitigates against sensorimotor deficits as a potential explanation for any impaired performance in acquisition or retention of the location of the hidden platform in the Morris water maze. Others have reached the same conclusion with highly similar data on APPswe Tg2576 mice (8) . Moreover, our finding that there are no significant differences in escape latencies to the visible platform between NTg and X11b, and between APPswe and APPswe/X11b mice at any time studied (Fig. 3A and B) argues that the phenotype is due to APPswe and is not influenced by the presence of the X11b transgene. Thus, X11b overexpression has no detectable effect on escape latency to the visible platform in the Morris water maze.
We next analyzed escape latencies to reach the hidden platform in the Morris water maze. APPswe 12 -16 months but not 3 -5 months mice displayed significant deficits in spatial reference learning and memory as compared with NTg littermates. This was revealed by an increase in the escape latencies by APPswe mice on days 7 -9 of training ( Fig. 3C and D) and by analyses of swimming patterns in probe trials conducted on days 4, 7 and 10 of testing where the platform was removed. In addition, APPswe but not APPswe/X11b transgenics also showed an increase in latency to reach the platform compared with NTg and X11b littermates on day 4 of testing. This may be related to the first probe trial that occurred prior to testing on day 4. Indeed, others using these same water maze methods for testing have also shown an increase in escape latency by similarly aged (12 -18 months) APPswe mice on day 4 of testing following the first probe trial (8) . However, platform seeking behaviour was not noticeably different after the probe trial (no indications of thigmotaxis, circling or non-swimming/floating behaviour was observed) which supports the notion that the day 4 effect on APPswe mice is transient. Indeed, the data we present on escape latencies for APPswe and NTg littermates in the 12-16 months mice are remarkably similar to those described by others in similarly aged APPswe Tg2576 mice (8) .
Concordant with analyses of escape latencies, the probe trial data demonstrated significant reductions in mean time spent in the target quadrant and number of target crosses, and a significant increase in mean latency to swim to the platform location by APPswe mice (Fig. 4A-C) . These results are consistent with previous reports (8, 21) . There were no detectable differences between X11b and NTg mice in any of the tests. However, APPswe/X11b mice displayed significant improvements in both escape latencies and mean probe trial scores as compared with APPswe mice such that their performances were not significantly different from NTg or X11b animals (Figs 3C, D and 4). Thus, overexpression of X11b reduces Ab levels in the brains of APPswe mice and improves spatial reference learning and memory in 12 -16-month-old APPswe mice.
X11b rescues age-dependent deficits in LTP in APPswe mice
Defective learning and memory in APPswe mice has been associated with LTP deficits (6) . LTP was therefore analyzed at Schaffer-collateral pyramidal cell synapses in the CA1 of anaesthetized 3-5 and 12-16 months NTg, APPswe, X11b and APPswe/X11b mice. Tetanic stimulation produced LTP in all four genotypes at both ages (Fig. 5) . In 3 -5-month-old mice, there were no significant differences between any of the genotypes during the induction (10 -70 min), maintenance (70 -130 min) and late (130-180 min) phases (Fig. 5A and  B) . However, in 12-16 months APPswe mice, LTP declined more rapidly than in the other groups and was significantly less in both the maintenance and late phases (Fig. 5C and  D) . These data are consistent with earlier reports (6) . Notably, LTP in 12-16 months APPswe/X11b and X11b mice were not significantly different to NTg animals in any phase. Thus, expression of X11b alone has no discernable effect on LTP in either the 3 -5 or 12-16 months mice but rescues LTP deficits in APPswe/X11b animals.
DISCUSSION
X11b (mint2) is a member of a small family of related proteins which include X11a (also known as mint1) and X11g (also known as mint3) that bind to the intracellular domain of APP via PTB domains; X11a and X11b are the two neuronal-specific isoforms [see for reviews (14, 15) ]. Numerous studies have shown that overexpression of either X11a, X11b or X11g all inhibit Ab production (12, 16, 17, (26) (27) (28) (29) (30) . In contrast, the effect of loss of X11s on in vivo Ab production is less clear (17, (31) (32) (33) . However, of the three, X11b is expressed highest in the cerebral cortex, entorhinal cortex and hippocampus, regions of the brain most acutely affected in Alzheimer's disease (34) . Thus, our findings that overexpression of X11b reduces Ab levels and rescues learning, memory and LTP defects in APPswe mice has particular relevance for Alzheimer's disease.
X11b function is not properly understood but there is evidence that the X11s have synaptic roles. Thus, X11a and X11a/X11b double knockout mice have presynaptic defects involving altered neurotransmitter release (35 -37) . In apparent contrast to the above, other studies provide evidence for post-synaptic functions for the X11s and in particular in the trafficking of NMDA receptors (38 -40) . Finally, the X11s may be involved in synaptic targeting of N-type calcium channels and Kir2 potassium channels (41, 42) . However, as yet there are no reports on electrophysiological characterization of X11b single knockout mice and this confounds the proper interpretation of the role of X11b in synaptic function. This is especially so since there is now strong evidence that the different X11s have unique functions. For example, X11a and X11b but not X11g bind munc-18, and X11a but not X11b or X11g binds to the CASK/mLin-2 and Veli/mLin7 complex (43 -45) . There is even some evidence that the effects of X11a and X11b on APP and Ab production may involve different underlying mechanisms (33, 46) .
What we show here is that overexpression of X11b has no discernible effect on learning, memory and LTP in X11b single transgenics and this is highly complementary to those of a recent study on X11b knockout mice which likewise demonstrate no role for X11b in learning and memory (also using the Morris water maze) (47) . Thus, neither overexpression nor loss of X11b influences hippocampal dependent Ã Indicates significant differences (P , 0.05 t-test). Error bars are + SEM.
learning and memory functions. A large body of evidence now demonstrates that learning, memory and associated LTP defects in APPswe Tg2576 mice and other Alzheimer's APP mice are due to increased cerebral levels of Ab and/or specific Ab assemblies (5 -9,21,48 -52). Thus, the most likely interpretation for the restoration of learning, memory and LTP in APPswe/X11b mice is X11b-mediated reduction in brain Ab levels. However, we cannot exclude the possibility that there are learning mechanisms (as opposed to simply locomotor ones) that are impaired in APPswe mice that are Ab-independent, X11b-resistant or both. The precise molecular mechanisms by which the X11s inhibit Ab production are not properly understood. Ab is produced by consecutive processing of APP by b-and g-secretases. b-secretase (BACE1) cleaves APP at the aminoterminus of the Ab sequence and g-secretase (comprising Presenilin, Nicastrin, APH-1 and PEN-2) at the carboxy-terminus of the Ab sequence (53, 54) . Some studies suggest that the X11s inhibit g-secretase cleavage while others propose they inhibit b-secretase cleavage of APP (55, 56) . Recently, the X11s have been shown to regulate BACE1 processing of APP by altering APP compartmentalization into detergent-resistant domains within membranes (lipid rafts) or microdomains such that APP and BACE1 are in different membranous compartments (31, 57) . This may involve altered trafficking of APP and indeed the X11s are linked to kinesin family molecular motors. X11a binds to the kinesin KIF17 and X11b binds to alcadein/calsyntenin, a scaffolding protein that interacts with kinesin-1 (20, 38, 58, 59) . In particular, the X11s and/or alcadein/calsyntenin may be involved in trafficking APP from the Golgi (17, 60) . Finally, the X11s also interact with the copper chaperone for superoxide dismutase-1 (CCS) and CCS additionally binds BACE1 (61, 62) . The roles of CCS on APP processing and Ab production are not known but its interaction with both BACE1 and X11 provides a further route whereby the X11s might inhibit brain Ab production. Whatever the precise mechanism, the data presented here which demonstrate that X11b not only No significant differences were detected between any genotype in 3 -5 months mice (two-way ANOVA) and all genotypes showed significant improvement in escape latencies over the testing period (both days 1 and 2 versus days 5-9, P , 0.05; two-way ANOVA with LSD post hoc test). Twelve to 16 months NTg, X11b and APPswe/X11b likewise showed significant improvement in escape latencies over the testing period (day 1 versus days 7, 8 and 9, P , 0.05; two-way ANOVA with LSD post hoc test). However, in 12-16 months mice, latencies were specifically increased in APPswe compared with all other genotypes on days 7, 8 and 9 of testing and this effect was rescued in APPswe/X11b mice (two-way ANOVA with LSD post hoc test; P , 0.01 day 7; P , 0.001 days 8 and 9). In addition, APPswe (but not APPswe/X11b) mice showed a significant increase in escape latency compared NTg and X11b mice on day 4 (P , 0.01 two-way ANOVA).
Ã Indicates significant differences between APPswe and all other genotypes. n ¼ 12-20 for 3 -5 months mice; n ¼ 17-21 for 12-16 months mice. Error bars are + SEM.
reduces cerebral Ab load but also corrects the associated cognitive and synaptic plasticity defects, validate modulation of X11b function as a therapeutic target for Alzheimer's disease.
MATERIALS AND METHODS
Transgenic mice
APPswe Tg2576 mice obtained from Taconic farms (Germantown, NY, USA) were maintained by breeding males with C57Bl/6/SJL F 1 females as recommended by the suppliers. X11b transgenic line 42 mice generated from C57Bl/6/SJL embryos have been described previously and were backcrossed onto C57Bl/6 eight times prior to crossing with APPswe Tg2576 animals. Male APPswe mice were mated with female X11b mice and offspring genotyped by PCR using primer sets 5 0 -CGACTCGACCAGGTTCTGGGT-3 0 , 5 0 -ATAACCCCTCCCCCAGCCTAGA-3 0 (APP) and 5 0 -TG AAGAACCAAACCCAGGTAAAGC-3 0 , 5 0 -CTACAGATCC TCTTCTGAGATGAG-3 0 (X11b). Mice were housed on 12 h light:12 h dark cycles. All experiments were performed under the terms of the UK Animals (Scientific Procedures) Act 1986.
Behavioural testing
Experimenters were blind to genotype for all behavioural testing. Mice were initially assessed for sensorimotor function using a modified SHIRPA primary screen (22) . For open field testing of locomotor function and exploratory activity, we used a white circular arena (80 cm diameter) with a 60 cm high wall, surrounded by a visually uniform environment. For single trials, mice were placed into the edge of the arena, facing the wall, and allowed to explore for 10 min. Trials were monitored and analyzed using the Ethovision package (Noldus, The Netherlands). We measured total locomotor activity plus time spent in, and visits to, the central (60 cm diameter) more anxiogenic zone. Rearing frequencies were monitored using Ethovision software.
Hippocampus-dependent spatial reference learning and memory were tested using a version of the Morris water maze task that has been specifically designed for APPswe Tg2576 mice, the Alzheimer's disease mouse model used here (8, 21) . This involved visible platform training followed by hidden platform testing with three rounds of probe trials (8, 21) . We used a white 1.4 m pool filled with water (22 -248C) opacified using Opacifier E308 (Rohm and Haas, UK). Mice underwent visible platform (10 cm diameter) training for three consecutive days with each days training split into two blocks of four trials. During visual training, a curtain was drawn around the pool to remove any visual cues. The platform location (NE, SE, SW or NW) and start positions (N, NE, E, SE, S, SW, W or NW) were varied pseudorandomly between these trials although start positions were never immediately adjacent to the platform. A black and white striped flagpole was situated in the centre of the platform to mark its location. Hidden platform training was conducted over the next 9 days (four trials per day) where mice searched for the platform now submerged 1.5 cm below the water surface. The location of the platform remained constant during hidden platform trials and the mice entered the pool in one of the pseudorandomly selected locations excluding the positions immediately adjacent to the platform. Mice that were unable to find the platform within 60 s were led to it with an escape scoop. In aged mice, probe trials were performed on the beginning of the 4th, 7th and 10th days of hidden platform training, when the platform was removed and mice allowed 60 s search time. Trials were recorded and analyzed using Ethovision. Time taken to reach the platform (escape latency) during each trial was monitored. During probe trials, time in target quadrant, latency to platform location and number of platform crosses were measured and mean performance across the three trials determined as previously described (63, 64) .
Ab assays
Human Ab 1 -40 and Ab 1 -42 levels in the brains of mice were determined using ELISA kits (TKHS-Set, The Genetics Company, Switzerland) essentially following the manufacturers instructions. Samples for analyses were prepared as Tris -HCl-soluble and formic acid-soluble fractions as .
Ã Indicate significant differences. Error bars are + SEM. described previously (16) . Briefly, brains were prepared for assay by homogenization as 20% homogenates in 20 mM Tris -HCl pH 8.0 containing 5 mM EDTA plus Complete protease inhibitor cocktail (Roche) (Assay buffer) using a Dounce homogenizer. Thereafter, the samples were spun at 100 000 g(av) for 1 h and the supernatant containing soluble Ab then removed and diluted as appropriate in Assay buffer for analyses (Tris -HCl-soluble Ab). To assay for insoluble Ab, the remaining pellet was extracted as a 15% homogenate in 70% formic acid by sonication at level 4 for 35 s using a Vibra Cell Disruptor (Sonic & Materials Inc.) and the mixture then spun at 100 000 g(av) for 1 h and the supernatant removed and diluted 1:20 with 1 M Tris to neutralize the pH. The samples were then diluted as appropriate in Assay buffer for analyses (formic acid-soluble Ab). Signals from ELISA were quantified at 450 nm using a microplate reader (Victor 3 1420, Perkin Elmer).
Electrophysiology
Mice underwent in vivo electrophysiological testing to investigate changes in hippocampal LTP essentially as previously described (65) . Mice were anaesthetized with urethane (1.2-1.8 g/kg i.p.) followed by supplemental injections as required and fixed in a stereotaxic frame with bregma and lambda in the same horizontal plane. Body temperature was maintained at 378C using an electrical heating pad. Bipolar stimulating electrodes were placed in the Schaffer-commissural input to CA1 of the left cerebral hemisphere (coordinates: 1.0 mm posterior to bregma; 0.5 mm lateral; 2.0 mm below brain surface), and the recording electrodes were sited in the left stratum oriens (2.2 mm posterior to bregma; 1.5 mm lateral; 1.2 mm below brain surface). After optimization and stabilization of evoked, negative-going, field excitatory postsynaptic potentials (fEPSPs), pulse pairs (200 ms pulse width, 50 ms interpulse interval, 2 pulse pairs per minute) were delivered at an intensity producing fEPSPs with 40% of the maximal amplitude to obtain 20 min of baseline responses (220 to 0 min). For analytical purposes, slopes of four consecutive fEPSPs were averaged to provide one mean of fEPSP over each 2 min period. The data analysis sections were divided into induction phase (10 -70 min), maintenance phase (70 -130 min) and late phase LTP (130 -180 min). Input -output curves, expressed as percentages of the maximum fEPSP slopes against stimulating current, were obtained for the four genotypes in both the 3 -5 and 12-16-month-old mice. 
